+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Keloid Treatment Market (2021-2026) by Product, Type, End user,, Geography and the Impact of Covid-19 with Ansoff Analysis

  • PDF Icon


  • 130 Pages
  • April 2021
  • Region: Global
  • Infogence Global Research
  • ID: 5317294
UP TO OFF until Sep 30th 2022
A keloid is a tough heaped-up scar that rises above the rest of the skin, generally pink or purple. Keloids have irregularly shaped scar that develops on the skin and enlarges progressively. According to the American Burn Association, in 2016, more than 40,000 hospitalizations resulted from burn injuries. This leads to increased demand for hypertrophic and keloid scar treatments.

The global keloid treatment market is expected to grow due to the rapid development made by the technologically upgraded skincare products. Also, growing awareness amongst the people regarding the availability of treatment options and other products available to cure keloid is a key factor in helping the keloid treatment market growth. The introduction of technologically advanced products, such as laser therapies, will also support market growth. These products help to reduce scars caused due to burns, trauma injuries, and surgery. These factors, coupled with a subsequent increase in the number of cosmetic procedures, has accelerated the demand for topical products.

Market Dynamics

  • Increase in the demand for aesthetics
  • Growth in the number of road accidents and burn cases
  • Increase in the availability of technologically advanced products

  • The high cost of laser-based products

  • Emerging economies provide a pool of opportunities to market players
  • Growing awareness among people regarding the availability of treatment options
  • General preference for plastic surgeries due to technical advancement in treatment procedures.

Segments Covered

Based on product type, the global keloid treatment market is segmented into Elastic Wraps, Sprays, Ointment, Creams, Oils, Topical Gels & Gel Sheets. In 2020, elastic wraps are expected to bear the fastest growth over the forecast period owing to its increase in demand and general use. Elastic wraps are widely used as a stretchable bandage to create localized pressure by segments of end-user of the keloid treatment market.

Based on treatment, the global keloid treatment market is segmented into ligature, radiation therapy, surgical treatment, laser treatment, steroid injections, corticosteroid injections (intralesional steroids), Silicone gel or sheeting, interferon. In 2020, the laser instruments segment is expected to exhibit the fastest growth over the forecasted period as laser treatments are comparatively painless. Besides, they have numerous other benefits, such as minimized healing time and lesser adverse effects. Injectable held a significant share of the market in 2017, as they proved to be rapid and cost-effective alternatives.

Based on end-users, the global keloid treatment market is segmented into dermatology clinics, hospitals, ambulatory surgical centers. Hospitals generated the maximum revenue in 2020 due to the availability of a wide range of treatment options for scar removal. In case of emergencies, such as major accidents, hospitals are the preferred choice of treatment as they provide care during the recovery period as well.

North America held the largest market share in the global keloid treatment market and is likely to witness steady development in the coming years. The high prevalence of burn injuries, skin-related disorders, and trauma are among the major factors responsible for market expansion. Moreover, the availability and adoption of advanced treatment options, such as laser treatments are estimated to support the growth.

The global keloid treatment market is segmented based on product, type and end user.

Keloid Treatment Market, By Product
  • Elastic Wraps
  • Sprays
  • Ointment
  • Creams
  • Oils
  • Topical Gels & Gel Sheets

Keloid Treatment Market, By Type
  • Ligature
  • Radiation Therapy
  • Cry Therapy
  • Surgical Treatment
  • Laser Treatment
  • Steroid Injections
  • Corticosteroid injections (intralesional steroids)
  • Silicone gel or sheeting
  • Interferon

Keloid Treatment Market, by End User
  • Dermatology clinics
  • Hospitals
  • Ambulatory surgical centers
  • Others

Keloid Treatment Market, By Geography
  • North America
  • South America
  • Europe
  • Asia Pacific
  • Middle East and Africa

Company Profiles

Some key players operating in the hypertrophic and keloid scar treatment market include Valeant, RXi Pharmaceuticals, Novartis, and Pacific World Corporation, Smith & Nephew PLC, Enaltus, LLC, Merz, Inc, Lumenis, Sonoma Pharmaceuticals, Cynosure, Inc, Scar Heal, Inc., Mölnlycke Health Care AB, and Perrigo Company plc.

Competitive Quadrant

The report includes a Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share etc.

  • Lions: Represents companies with a strong foothold in the market, with the highest market share, large investments in technologies, new products.
  • Bulls: Companies that are medium in size competing with their USPs, growing companies with proven market share.
  • Rabbits: Small companies but growing rapidly, constantly improving their offerings in the market
  • Tortoise: Companies which are slow in growth, having a long legacy and stable or negative in performance

Why buy this report?

  • The report offers a comprehensive evaluation of the Global Keloid Treatment Market.
  • The report includes in-depth qualitative analysis, verifiable data from authentic sources and projections about market size. The projections are calculated using proven research methodologies.
  • The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys and observation of renowned personnel in the industry.
  • The report includes in-depth market analysis using Porter’s 5 force model and the Ansoff Matrix. The impact of Covid-19 on the market is also featured in the report.
  • The report also contains the competitive analysis using Competitive Quadrant, the analyst's proprietary competitive positioning tool.

Report Highlights:
  • A complete analysis of the market including parent industry
  • Important market dynamics and trends
  • Market segmentation
  • Historical, current, and projected size of the market based on value and volume
  • Market shares and strategies of key players
  • Recommendations to companies for strengthening their foothold in the market

Table of Contents

1. Report Description
1.1 Study Objectives
1.2 Market Definition
1.3 Currency
1.4 Years Considered
1.5 Language
1.6 Key Shareholders
2. Research Methodology
2.1 Research Process
2.2 Data Collection and Validation
2.2.1 Secondary Research
2.2.2 Primary Research
2.3 Market Size Estimation
2.4 Assumptions of the Study
2.5 Limitations of the Study
3. Executive Summary
4. Market Overview
4.1 Introduction
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Trends
5. Market Analysis
5.1 Porter’s Five Forces Analysis
5.2 Impact of COVID-19
5.3 Ansoff Matrix Analysis
6. Keloid Treatment Market, by product type
6.1 Elastic Wraps
6.2 Sprays
6.3 Ointment
6.4 Creams
6.5 Oils
6.6 Topical Gels & Gel Sheets
7. Keloid Treatment Market, By Treatment
7.1 Ligature
7.2 Radiation Therapy
7.3 Cry Therapy
7.4 Surgical Treatment
7.5 Laser Treatment
7.6 Steroid Injections
7.7 Corticosteroid injections (Intralesional steroids)
7.8 Silicone gel or sheeting
7.9 Interferon
8. Keloid Treatment Market, by End User
8.1 Dermatology clinics
8.2 Hospitals
8.3 Ambulatory surgical centers
8.4 Others
9. Keloid Treatment Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 South America
9.3.1 Brazil
9.3.2 Argentina
9.4 Europe
9.4.1 UK
9.4.2 France
9.4.3 Germany
9.4.4 Italy
9.4.5 Rest of Europe
9.5 Asia-Pacific
9.5.1 China
9.5.2 Japan
9.5.3 India
9.5.4 Australia
9.5.5 Rest of APAC
9.6 Middle East and Africa
10. Competitive Landscape
10.1 Competitive Quadrant
10.2 Market Share Analysis
10.3 Competitive Scenario
10.3.1 Mergers & Acquisitions
10.3.2 Agreements, Collaborations, & Partnerships
10.3.3 New Product Launches & Enhancements
10.3.4 Investments & Funding
11. Company Profiles
11.1 Valeant
11.1.1 Introduction
11.1.2 Financial Overview
11.1.3 Product Portfolio
11.1.4 Recent Developments
11.1.5 Key personnel
11.2 RXi Pharamaceuticals
11.3 Novartis
11.4 Pacific World Corporation
11.5 Smith & Nephew
11.6 Enaltus
11.7 Merz
11.8 Lumenis
11.9 Sonoma Pharmaceuticals
11.10 Cynosure
11.11 Scar Heal
11.12 Mölnlycke Health Care AB
11.13 Perrigo Company plc
11.14 NewMedical Technology
12. Appendix
12.1 Questionnaire

Companies Mentioned

  • Valeant
  • RXi Pharamaceuticals
  • Novartis
  • Pacific World Corporation
  • Smith & Nephew
  • Enaltus
  • Merz
  • Lumenis
  • Sonoma Pharmaceuticals
  • Cynosure
  • Scar Heal
  • Mölnlycke Health Care AB
  • Perrigo Company plc
  • NewMedical Technology